Region: Global
Category: Diagnostics

Global Diagnostics

(6,859 reports matching your criteria)
  • Oncology Companion Diagnostics Global Market Report 2025

    ... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More

  • DNA Probes-Based Diagnostics

    ... at a CAGR of 9.4% over the analysis period 2024-2030. Infectious Diseases, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$20.4 Billion by the end of ... Read More

  • Diabetes Diagnostics

    ... CAGR of 8.5% over the analysis period 2024-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More

  • Interventional Radiology Systems

    ... at a CAGR of 7.1% over the analysis period 2024-2030. MRI Systems, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.7 Billion by the end of ... Read More

  • Oncology Based In-Vivo CRO

    ... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Solid Tumors, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.2 Billion by the ... Read More

  • Ultrasound Image Analysis Software

    ... 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Integrated, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.2 Billion by the end ... Read More

  • Digital Pathology Systems

    ... at a CAGR of 12.8% over the analysis period 2024-2030. Device, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$1.1 Billion by the end of the ... Read More

  • BioImaging Technologies

    ... CAGR of 15.0% over the analysis period 2024-2030. Medical, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$19.5 Billion by the end of the analysis period. ... Read More

  • Prenatal Diagnostics

    ... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis period. ... Read More

  • Radiation Therapy Equipment

    ... at a CAGR of 6.6% over the analysis period 2024-2030. External Beam Radiation Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.1 Billion by the ... Read More

  • Medical Ultrasound Equipment

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$5.2 Billion by the end of the ... Read More

  • Electrophoresis Equipment and Supplies

    ... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More

  • Forensic Technologies and Services

    ... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More

  • ADME-Toxicology Testing

    ... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More

  • Metabolic Testing Solutions

    ... at a CAGR of 6.8% over the analysis period 2024-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$324.1 Million by the end of ... Read More

  • Commercial Biotechnology Separation Systems

    ... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the end ... Read More

  • Radiofrequency Ablation Devices for Pain Management

    ... reach US$1.4 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Disposable Products, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach ... Read More

  • Cerebral Angiography

    ... CAGR of 6.6% over the analysis period 2024-2030. Magnetic Resonance Angiography Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$36.8 Million by the end of ... Read More

  • Veterinary Rapid Testing

    ... at a CAGR of 8.3% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the ... Read More

  • Rabies Diagnostics

    ... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end of ... Read More

  • Medical X-Ray

    ... CAGR of 5.1% over the analysis period 2024-2030. Digital, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$13.5 Billion by the end of the analysis period. ... Read More

  • Bone Densitometers

    ... CAGR of 5.6% over the analysis period 2024-2030. Axial Bone Densitometers, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$264.5 Million by the end of the ... Read More

  • Industrial Computed Tomography Equipment

    ... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Equipment Offering, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$485.4 Million by the ... Read More

  • Mobile MRI Services

    ... at a CAGR of 3.5% over the analysis period 2024-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$1.3 Billion by the end of ... Read More

  • Blood Culture Tests

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Conventional Blood Culture Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings